Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis

Area of Science:

• Immunology
• Inflammation Research
• Sepsis Pathophysiology

Background:

• Complement factor C5a (C5a) is known to promote inflammation via C5a receptor 1 (C5ar1).
• Emerging evidence indicates C5a also mediates anti-inflammatory effects.
• The precise role of C5ar1 in sepsis remains to be fully elucidated.

Purpose of the Study:

• To investigate the therapeutic potential of targeting C5ar1 in a murine model of sepsis.
• To determine the impact of C5ar1 deficiency on sepsis outcomes and immune modulation.

Main Methods:

• Utilized a murine sepsis model to compare wild-type and C5ar1-deficient mice.
• Assessed survival rates, pathogen clearance, liver function, and cytokine profiles (interferon-γ and interleukin-10).

Main Results:

• C5ar1-deficient mice showed significantly increased survival in mild to moderate sepsis, but not severe sepsis.
• Improved pathogen clearance and preserved liver function were observed in C5ar1-deficient mice.
• Deficiency in C5ar1 led to increased interferon-γ and decreased interleukin-10 production, altering the IFN-γ/IL-10 ratio.

Conclusions:

• C5a signaling through C5ar1 mediates immunosuppressive processes during sepsis.
• C5ar1 inhibition represents a potential therapeutic strategy for sepsis.
• The C5ar1 and the IFN-γ/IL-10 ratio serve as markers for immune dysfunction in sepsis.